Lazzaro, C., Mazzanti, N.A. and Parazzini, F. 2019. Severe haematological toxicities in relapsed ovarian cancer treated with olaparib or niraparib: an Italian cost-minimization analysis. Global and Regional Health Technology Assessment. 6, 1 (May 2019). DOI:https://doi.org/10.33393/grhta.2019.464.